Nonspecific analgesics, combination analgesics, and antiemetics

Copyright © 2024 Elsevier B.V. All rights reserved, including those for text and data mining, AI training, and similar technologies..

The acute treatment of migraine attacks should provide rapid, effective, and long-lasting symptom relief, causing minimal adverse effects. For this purpose, there are several specific and nonspecific acute treatments. In this chapter, we focus on molecules not specifically designed for migraines, including anti-inflammatory not specific analgesics, such as acetaminophen, acetylsalicylic acid, and other non-steroidal anti-inflammatory drugs (or COX-2 inhibitors); antinausea medications like metoclopramide or prochlorperazine, which can alleviate sickness and vomiting associated with migraines, and may also have a direct painkiller effect; combinations of simple analgesics or association of a painkiller with caffeine. This stimulant can help enhance the pain-relieving effects of some headache medications and provide its own analgesic effect; physical approaches: applying cold packs or heating pads on the forehead or neck, can help relieve migraine pain; other classes with limited to no evidence to support their use, such as intravenous corticosteroids or antiepileptic drugs as sodium valproate. Finally, we will briefly mention opioids, barbiturates, or medical cannabis, bearing in mind that their use is not recommended by current guidelines.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:199

Enthalten in:

Handbook of clinical neurology - 199(2024) vom: 02., Seite 3-16

Sprache:

Englisch

Beteiligte Personen:

Martinelli, Daniele [VerfasserIn]
Pocora, Maria Magdalena [VerfasserIn]
Tassorelli, Cristina [VerfasserIn]

Links:

Volltext

Themen:

Analgesics
Analgesics, Opioid
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antiemetics
Caffeine
Combination analgesics
Journal Article
NSAIDs
Nonsteroidal anti-inflammatory drugs
Review

Anmerkungen:

Date Completed 05.02.2024

Date Revised 05.02.2024

published: Print

Citation Status MEDLINE

doi:

10.1016/B978-0-12-823357-3.00035-5

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM367970295